![]() |
|
![]() |
||||
Thread | Thread Starter | Forum | Replies | Last Post |
PubMed: 'Next-generation' sequencing becomes 'now-generation'. | Newsbot! | Literature Watch | 0 | 01-22-2012 03:23 AM |
Call-for-papers: special issue on next-gen sequencing of IJFIPM | rnaseq_gui | Events / Conferences | 0 | 01-01-2012 08:36 AM |
Coming up in August: IBC's Next Generation Sequencing & Genomic Medicine | Kdostie | Events / Conferences | 0 | 05-26-2011 11:58 AM |
Call for papers and participants on Next Generation Sequencing (CAMDA 2009) | shoeboyon | Bioinformatics | 0 | 08-10-2009 09:00 AM |
How deep is credible to detect SNP or indel? | anyone1985 | Bioinformatics | 0 | 06-17-2009 11:39 PM |
![]() |
|
Thread Tools |
![]() |
#1 |
Member
Location: Nashville Join Date: Oct 2009
Posts: 14
|
![]()
Hi all,
I just read the following paper named Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays from Science Express. In this paper, a sequencing corporation, Complete Genomics, Inc., located at Mountain View, CA announced they will release the so-called third-generation sequecing technology with high coverage (45- to 87-fold coverage per genome) and very low price ($4,400). I was attracted deeply by this paper but with suspicion on this. So I try to contact with this corporation using its service email. But it's unfortunate that I have got any response even though 3 emails were sent until now. So I attach the abstract of this paper here and hope you can perform a evaluation on this so-called new technology. Thank you. Regards, Wuhoucdc PS: Published Online November 5, 2009 Science DOI: 10.1126/science.1181498 Science Express Index Reports Submitted on September 3, 2009 Accepted on October 23, 2009 Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays Radoje Drmanac 1*, Andrew B. Sparks 1, Matthew J. Callow 1, Aaron L. Halpern 1, Norman L. Burns 1, Bahram G. Kermani 1, Paolo Carnevali 1, Igor Nazarenko 1, Geoffrey B. Nilsen 1, George Yeung 1, Fredrik Dahl 2, Andres Fernandez 1, Bryan Staker 1, Krishna P. Pant 1, Jonathan Baccash 1, Adam P. Borcherding 1, Anushka Brownley 1, Ryan Cedeno 1, Linsu Chen 1, Dan Chernikoff 1, Alex Cheung 1, Razvan Chirita 1, Benjamin Curson 1, Jessica C. Ebert 1, Coleen R. Hacker 1, Robert Hartlage 1, Brian Hauser 1, Steve Huang 1, Yuan Jiang 1, Vitali Karpinchyk 1, Mark Koenig 1, Calvin Kong 1, Tom Landers 1, Catherine Le 1, Jia Liu 1, Celeste E. McBride 1, Matt Morenzoni 1, Robert E. Morey 3, Karl Mutch 1, Helena Perazich 1, Kimberly Perry 1, Brock A. Peters 1, Joe Peterson 1, Charit L. Pethiyagoda 1, Kaliprasad Pothuraju 1, Claudia Richter 1, Abraham M. Rosenbaum 4, Shaunak Roy 1, Jay Shafto 1, Uladzislau Sharanhovich 1, Karen W. Shannon 5, Conrad G. Sheppy 1, Michel Sun 1, Joseph V. Thakuria 4, Anne Tran 1, Dylan Vu 1, Alexander Wait Zaranek 4, Xiaodi Wu 6, Snezana Drmanac 1, Arnold R. Oliphant 1, William C. Banyai 1, Bruce Martin 1, Dennis G. Ballinger 1*, George M. Church 4, Clifford A. Reid 1 1 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA. 2 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA.; Present address: Ion Torrent Systems, San Francisco, CA, USA. 3 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA.; Present address: San Diego State University, San Diego, CA, USA. 4 Department of Genetics, Harvard Medical School, Cambridge, MA, USA. 5 Complete Genomics, Inc., 2071 Stierlin Court, Mountain View, CA 94043, USA.; Present address: Life Technologies, Carlsbad, CA, USA. 6 School of Medicine, Washington University, St. Louis, St. Louis, MO, USA. * To whom correspondence should be addressed. Radoje Drmanac , E-mail: rdrmanac@completegenomics.com Dennis G. Ballinger , E-mail: dballinger@completegenomics.com These authors contributed equally to this work. Genome sequencing of large numbers of individuals promises to advance the understanding, treatment, and prevention of human diseases, among other applications. We describe a genome sequencing platform that achieves efficient imaging and low reagent consumption with combinatorial probe anchor ligation (cPAL) chemistry to independently assay each base from patterned nanoarrays of self-assembling DNA nanoballs (DNBs). We sequenced three human genomes with this platform, generating an average of 45- to 87-fold coverage per genome and identifying 3.2 to 4.5 million sequence variants per genome. Validation of one genome data set demonstrates a sequence accuracy of about 1 false variant per 100 kilobases. The high-accuracy, affordable cost of $4,400 for sequencing consumables and scalability of this platform enable complete human genome sequencing for the detection of rare variants in large-scale genetic studies. Last edited by wuhoucdc; 11-11-2009 at 01:52 PM. Reason: Change the title |
![]() |
![]() |
![]() |
#2 |
Junior Member
Location: CA Join Date: Nov 2009
Posts: 5
|
![]()
Hi Wuhoucdc,
For some more information about this paper, I encourage you to review our website (http://www.completegenomics.com/data...ngResults.aspx). If you have some specific questions, we would be happy to address. You can contact us at info@completegenomics.com for general information or at dev-support@completegenomics.com for more detailed analysis support. Regards, Dione |
![]() |
![]() |
![]() |
#3 |
Member
Location: Nashville Join Date: Oct 2009
Posts: 14
|
![]()
Hi Dione,
After read more carefully on your website about this new technology, I think it will be applied rapidly on various domains. I hope this technology will bring us new chance among human genomics. Thank you. Best, Wuhoucdc |
![]() |
![]() |
![]() |
Thread Tools | |
|
|